MedPath

A multimodal cancer rehabilitation programme for women treated for gynaecological cancer

Not Applicable
Conditions
Women treated for gynaecological cancer
Cancer
Registration Number
ISRCTN17629214
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Female
Target Recruitment
160
Inclusion Criteria

1. Women with a primary diagnosis of gynaecological cancers (uterine, ovarian or cervical cancers)
2. Within 3 months of completion of intensive cancer treatments (e.g. surgery, radiotherapy, and /or chemotherapy)
3. Over 18 years old
4. Able to understand spoken Cantonese and to read Chinese
5. Having smartphones with iOS or Android operating systems
6. Consenting to participate

Exclusion Criteria

Those with unsuitable physical or mental health conditions, including visual impairment or preexisting psychosis, will be excluded as their ability to comprehend information and answer questionnaires would be affected.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sense of coherence measured using the Chinese version of the Sense of Coherence 13-item Scale (CSOC-13) at baseline, completion of the intervention, and 12 weeks after completion
Secondary Outcome Measures
NameTimeMethod
1. Cancer-specific distress measured using the Chinese version of the Impact of Events-Revised scale (CIES-R) at baseline, completion of the intervention, and 12 weeks after completion<br>2. Dietary and physical activity practices measured using the Chinese version of Health Promotion Lifestyle Profile II (HPLP-II) at baseline, completion of the intervention, and 12 weeks after completion<br>3. Health-related quality of life measured using the Chinese version of the Medical Outcomes Study (MOS) 36-item Short Form (SF-36) Health Survey at baseline, completion of the intervention, and 12 weeks after completion<br>4. Health-related quality of life measured using the Hong Kong version of the five-level EuroQol-5 Dimension (EQ-5D-5L) every three months from baseline to 12-month post-intervention<br>5. Participants' experiences, perceptions and opinions explored by semi-structured interviews upon completion of the intervention
© Copyright 2025. All Rights Reserved by MedPath